Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide plus reduced-volume PEG versus 4L PEG for colonoscopy bowel preparation in constipated adults
ChiCTR2400081524Phase 4Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Mar 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of linaclotide in constipation (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoints: Adequate bowel preparation rate, Cecal intubation rate and 1 more. Started Mar 2024; status: recruiting.
02
Drugs
linaclotide
03
Conditions
constipation
Beyond the preview
Go deeper on ChiCTR2400081524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081524.